Kraig Biocraft Laboratories (KBLB) FCF Margin (2016 - 2018)

Kraig Biocraft Laboratories (KBLB) has 3 years of FCF Margin data on file, last reported at 22.8% in Q3 2018.

• For the quarter ending Q3 2018, FCF Margin rose 54417.0% year-over-year to 22.8%; the trailing twelve-month figure through Jun 2019 stood at 393.01% (down 28432.0% YoY), and the FY2021 full-year result was 4744907.5%, changed N/A from the prior year.
• FCF Margin improved to 22.8% in Q3 2018, from 42.1% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 22.8% in Q3 2018 to a low of 1418.66% in Q4 2016.
• A 3-year average of 490.72% and a median of 123.07% in 2017 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin soared 129558 bps in 2017 and soared 54417 bps in 2018, its largest moves.
• Tracing KBLB's FCF Margin over 3 years: stood at 1418.66% in 2016, then soared by 91 bps to 123.07% in 2017, then soared by 81 bps to 22.8% in 2018.
• Business Quant data shows KBLB's FCF Margin at 22.8% in Q3 2018, 42.1% in Q2 2018, and 77.9% in Q1 2018.